| THE CONTENDERS |
|  LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Completetion of the maunfacturing of 182.5 million doses of ACAM2000 smallpox vaccine. Possible licensing of ACAM200 Third payment from Baxter of 2.6m in relation to the Canton manufacturing facility. ChimeriVax-JE initiate Phase III trials Data from C.Difficile Vaccine trials. Possible contract for MVA3000 expected February Initiate a clinical trial in HIV infected of MVA3000 Clarification on the future of Arilvax(TM) Company Summary |  Click here for Product Pipeline:  |
| 
LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Cetilistat - Updates from Takeda on clinical development in Japan [2005 AGM presentation] Cetilistat: Commencement of Phase III clinical programme Renzapride: News on the crystal form patent application. Colal-Pred: possible commencement of U.S. Phase III clinical trials in the treatment of acute ulcerative colitis. Company Summary |  Click here for Product Pipeline: |
|  LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Commencement of full Phase III studies on vaccines against allergy to the most common pollens. Pollinex(R) Quattro submission for registration in H1 2006. Company Summary |  Click here for Product Pipeline: |
| ANTISOMA LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Data on AS1404 in regards to disease progression and survival. R1550 phase I trial data on patients with metastatic (spreading) or locally advanced breast cancer. Starting of trials into AS1409 Starting of trials into AS1410 - H1 Company Summary |  Click here for Product Pipeline: |
| 
LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 H1 2006 Start PIII trial of Testo Cream H2 2006 Launch InvicorpTM H1 2006 Results from PII trial of Terbutaline H1 2006 InvicorpTM mutual recognition H2 2006 PIII data and regulatory submission of Testo Cream H1 2006 Teverelix LA and other collaborations Company Summary |  |
|  LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Phase II results of EG005 Company Summary |  Click here for Product Pipeline: |
| CeNeS LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Morphine-6-glucuronide (M6G) - Results of Phase III trial in Europe mid-2006 Results of consultation with FDA over IND status of M6G. Possibly resulting in a quicker commencement of PIII trials. Application for an IND for CNS 7056X in the US. Announcement of a new pre-clinical development candidate before mid-2006. Company Summary |  Click here for Product Pipeline: |
| Evolutec LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 rEV598 - Complete preclinical studies (Due end of 2005) rEV131 - NDA submission end 2006 Company Summary |  Click here for Product Pipeline: |
| 
LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Awaiting Year End Results Company Summary |  Click here for Product Pipeline: |
|  LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 2005-2006 TroVax commercial collaboration H1 2006 TroVax Special Protocol Assessment for Phase III from FDA H1 2006 ProSavin regulatory approval for start of Phase I/II trial H1 2006 MetXia Phase II efficacy data in pancreatic cancer May 2006 TroVax Phase II full report in colorectal cancer (ASCO1) Mid 2006 TroVax Phase III trial in renal cancer to start H2 2006 ProSavin Phase I/II trial in Parkinsons disease to start 2006 TroVax Phase II trial in breast cancer to start (NCI2) 2006 MAb-toxin Phase I/II trial in cancer to start (Wyeth2) 2006 Canine TroVax-Vet trial in cancer to start (Intervet2) Company Summary |  Click here for Oncology Product Pipeline: Click here for Neurotherapy Product Pipeline: |
| 
LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 None as of yet, Awaiting Merger completion Company Summary |  Click here for Product Pipeline: |
|  LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Hoodia Gordonii - Commencement of Clinical Studies. Asthma - Start of proof of concept studies. Company Summary |  Click here for Product Pipeline: |
| 
LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Tostrex is expected to be launched in certain other European territories during the second half of 2006. Rectogesic is expected to be launched in certain other European territories during 2006. Oestradiol-glucoside Subject to obtaining FDA approval, it is currently envisaged that the study will be initiated in 2006 and will complete in 2007. Transdermal anti-emetic patch ProStrakan anticipates initiation of Phase III trials in Q4 2005 with results in 2006 and earliest launch in 2008. Testosterone-glucoside a single and multiple dose Phase IIa study with candidate formulations is planned to provide data mid 2006 Company Summary | 
Click here for Product Pipeline |
|  LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Awaiting End of Year Results Company Summary |  Click here for Product Pipeline: |
|  LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Submission of manufacturing changes to CroFab(TM) DigiFab -UK Product Launch Q1 EU approval of DigiFab Vorazaze - US approval H1 Vorazaze - European approval H2 Prolarix - Start of Phase II study in HCC (Mid 2006) Aniotensin Vaccine - Start of Phase IIa study H1 Company Summary |  Click here for Product Pipeline: |
LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Completion of VR004 Phase IIb Clinical evaluation of VR040 to commence Company Summary | 
Click here for Product Pipeline: |
| Vernalis LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Frovatriptan: MRM efficacy data H1 06 Frovatriptan: MRM regulatory submission H1 06 V10153: Completion of Phase IIa in stroke H1 06 V1003: Completion of Phase IIa (Reckitt Benckiser) H1 06 V24343: Start of Phase I in obesity and related disorders H2 06 Apokyn Half Yearly sales data H2 06 Company Summary |  Click here for Product Pipeline: |
| XTLbio LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 Awaiting Final Results End of December Company Summary |  Click here for Product Pipeline: |
| York Pharma LATEST NEWS | Click Here for Company Website Click Here for Discussion 2006 YP006 New Abasol indication - Formulation validation ongoing and entering clinical development in 2006 Meeting with FDA regarding Abasol Abasol - filing in Japan and US H2 Company Summary |  Click here for Product Pipeline: |
- 28 Dec 2005 17:45
Follow us on Twitter